Go, go, go! UK antitrust class actions given green light to proceed to trial

Google/Fitbit: The EU Commission misses a step

Handling competitively sensitive information in a vertically integrated firm: Practical antitrust advice for in-house counsel

The Achilles’ heel that can frustrate a global transaction: Voluntary merger notification regimes

The EU Court of Justice dismisses the appeals of several manufacturers of medicines against the General Court’s judgment upholding the Commission’s pay-for-delay infringement decision (Lundbeck)

The UK National Security and Investment Bill: Impact on transactions concerning intangible assets

Working group to update pharmaceutical merger review in the US, Canada, UK and Europe

A good influence? Investor liability for antitrust infringements by companies in which they invest

South African Competition Commission reveals wide scope of buyer power provisions

The impact of Brexit on antitrust and competition

Competition Bureau Publishes Final IP Enforcement Guidelines

Enhancing The "Carrot": DOJ Announces Changes to Its Antitrust Compliance Program Policy

Fair(er) Antitrust Enforcement: Will the ICN’s New Global Framework Improve Procedural Fairness for Businesses?

Nothing to see here! Clearing the Deal in the Initial HSR Waiting Period

The European Commission’s Report on Syndicated Loans and Competition Compliance

The Repeal of the IP Exception : Competition Law Exposure in the Pharmaceutical and Life Sciences Sector

Understanding the FTC’s Monetary Equitable Remedies Under Section 13(b) for Antitrust Violations